Organon & Co. (OGN)
9.59
+0.13
(+1.37%)
USD |
NYSE |
Jan 21, 16:00
9.64
+0.05
(+0.52%)
Pre-Market: 09:26
Organon Cash from Investing (Quarterly): -115.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -283.00M |
| Amgen, Inc. | -414.00M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Rockwell Medical, Inc. | -4.309M |
| United Therapeutics Corp. | 140.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 264.00M |
| Cash from Financing (Quarterly) | -76.00M |
| Free Cash Flow | 598.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5716 |
| Free Cash Flow to Equity (Quarterly) | 217.00M |
| Free Cash Flow to Firm (Quarterly) | 235.26M |
| Free Cash Flow Yield | 23.94% |